Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Using an Endogenous CRISPR-Cas System for Genome Editing in the Human Pathogen Clostridium difficile.

Maikova A, Kreis V, Boutserin A, Severinov K, Soutourina O.

Appl Environ Microbiol. 2019 Oct 1;85(20). pii: e01416-19. doi: 10.1128/AEM.01416-19. Print 2019 Oct 15.

PMID:
31399410
2.

New Insights Into Functions and Possible Applications of Clostridium difficile CRISPR-Cas System.

Maikova A, Severinov K, Soutourina O.

Front Microbiol. 2018 Jul 31;9:1740. doi: 10.3389/fmicb.2018.01740. eCollection 2018. Review.

3.

Discovery of new type I toxin-antitoxin systems adjacent to CRISPR arrays in Clostridium difficile.

Maikova A, Peltier J, Boudry P, Hajnsdorf E, Kint N, Monot M, Poquet I, Martin-Verstraete I, Dupuy B, Soutourina O.

Nucleic Acids Res. 2018 May 18;46(9):4733-4751. doi: 10.1093/nar/gky124.

4.

The HSP70 chaperone machines of Chlamydomonas are induced by cold stress.

Maikova A, Zalutskaya Z, Lapina T, Ermilova E.

J Plant Physiol. 2016 Oct 1;204:85-91. doi: 10.1016/j.jplph.2016.07.012. Epub 2016 Jul 25.

PMID:
27543887
5.

Temporal dynamics of methyltransferase and restriction endonuclease accumulation in individual cells after introducing a restriction-modification system.

Morozova N, Sabantsev A, Bogdanova E, Fedorova Y, Maikova A, Vedyaykin A, Rodic A, Djordjevic M, Khodorkovskii M, Severinov K.

Nucleic Acids Res. 2016 Jan 29;44(2):790-800. doi: 10.1093/nar/gkv1490. Epub 2015 Dec 19.

Supplemental Content

Loading ...
Support Center